๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Venous Thromboembolic Event

DOAC in Chinese Patients With Atrial Fibrillation NCT05378035n/a1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Blood Tests Apixaban in Thrombocytopenia NCT06886516EARLY Phase 11 site๐Ÿ“ Boston Rushad Patell ยท Tests: Apixaban Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance NCT07855679n/a16 sites๐Ÿ“ Bagno a Ripoli๐Ÿ“ Borgo San Lorenzo๐Ÿ“ Empoli Azienda Ospedaliero-Universitaria Careggi ยท Tests: Routine clinical care (no study intervention) Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis NCT06958588Phase 41 site๐Ÿ“ Belo Horizonte Science Valley Research Institute ยท Tests: Experimental: Hyperslim, Active Comparator #1 Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty NCT06963320Phase 21 site๐Ÿ“ Shanghai Livzon Pharmaceutical Group Inc. ยท Tests: H001 Capsule 200mg-qd, Enoxaparin Sodium Injection, H001 Capsule 300mg-qd, H001 Capsule 200mg-bid DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis NCT05701917NA64 sites๐Ÿ“ Scottsdale๐Ÿ“ Tucson๐Ÿ“ Orange Inari Medical ยท Tests: ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Hepโ€ฆ Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk NCT06845423Phase 418 sites๐Ÿ“ Amiens๐Ÿ“ Bordeaux๐Ÿ“ Brest University Hospital, Brest ยท Tests: Low molecular weight heparin Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers NCT07493304Phase 313 sites๐Ÿ“ Hialeah๐Ÿ“ New York๐Ÿ“ El Paso Regeneron Pharmaceuticals ยท Tests: REGN7508, Apixaban Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study) NCT07372716NA1 site๐Ÿ“ Ottawa Ottawa Hospital Research Institute ยท Tests: standardized perioperative anticoagulation management Guideline Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET) NCT06057844NA1 site๐Ÿ“ Brest University Hospital, Brest ยท Tests: Additional blood sampling inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT NCT06581965Phase 413 sites๐Ÿ“ Apeldoorn๐Ÿ“ Geleen๐Ÿ“ Geldrop Leiden University Medical Center ยท Tests: Short duration prophylaxis, Higher intensity and longer duration prophylaxis, Control Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West NCT05773638n/a6 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Caen University Hospital, Brest VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization NCT06873321Phase 41 site๐Ÿ“ Pernambuco Science Valley Research Institute ยท Tests: rivaroxaban 2.5 mg bid + aspirin 100 mg, clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovasculโ€ฆ Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management NCT07464808NA1 site๐Ÿ“ Cairo Ain Shams University ยท Tests: follow up venous thrombo embolic events with routine clexan dose modification guided by anti factor 10 assay, follow upโ€ฆ Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis NCT04874428Phase 11 site๐Ÿ“ Bern Insel Gruppe AG, University Hospital Bern ยท Tests: Rivaroxaban 10 mg Oral Tablet, Apixaban 2.5 mg Oral Tablet Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes NCT07820670NA1 site๐Ÿ“ Holon Wolfson Medical Center ยท Tests: Rivaroxaban, Enoxaparin 40 mg Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis NCT07801638NA1 site๐Ÿ“ Beijing Capital Medical University ยท Tests: Tocilizumab, Standard Treatment Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies NCT07270263NA1 site๐Ÿ“ Gdansk Medical University of Gdansk ยท Tests: Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism NCT06382038NA1 site๐Ÿ“ Beijing Navy General Hospital, Beijing ยท Tests: mobile venous thromboembolism application (mVTEA) A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA NCT07140523Phase 21 site๐Ÿ“ Novรฉ Mฤ›sto na Moravฤ› Sirius Therapeutics Co., Ltd. ยท Tests: SRSD107, enoxaparin REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis NCT07410117Phase 323 sites๐Ÿ“ Hialeah๐Ÿ“ North Miami Beach๐Ÿ“ New York Regeneron Pharmaceuticals ยท Tests: REGN7508, Placebo Focused Ultrasound of the Popliteal Fossa for Detection of Symptomatic Baker's Cysts in Patients With Suspected Deep Vein Thrombosis: A Pilot Diagnostic Accuracy Study NCT07791017n/a1 site๐Ÿ“ Aarhus Aarhus University Hospital ยท Tests: Index Test (Focused Ultrasound of the Popliteal Fossa), Reference test (Routine DVT Diagnostic Pathway) Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study NCT05089227Phase 21 site๐Ÿ“ Dijon Centre Hospitalier Universitaire Dijon ยท Tests: treatment "intervention", treatment "standard", biological assessment Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam NCT07083609n/a1 site๐Ÿ“ Hanoi Hieu Trung Dinh ยท Tests: Dabigatran, Rivaroxaban Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial NCT06523959Phase 41 site๐Ÿ“ Helsinki Clinical Urology and Epidemiology Working Group ยท Tests: Apixaban 2.5 MG Pregnancy and Risk of Venous Thromboembolism NCT03659708NA1 site๐Ÿ“ Bron Hospices Civils de Lyon ยท Tests: Lyon-VTE score, recommendations currently available AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial. NCT06939803NA1 site๐Ÿ“ Nashville Vanderbilt University Medical Center ยท Tests: Risk model-driven CDS VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE NCT02156401n/a1 site๐Ÿ“ Mainz Johannes Gutenberg University Mainz Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) NCT06440694Phase 34 sites๐Ÿ“ Ottawa๐Ÿ“ Windsor๐Ÿ“ Montreal Ottawa Hospital Research Institute ยท Tests: Colchicine 0.5 mg po, Placebo 0.5 mg po Cohort for Monitoring Patients With Venous Thromboembolic Disease NCT07016542n/a1 site๐Ÿ“ Rouen University Hospital, Rouen
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy